×

Repair Biotechnologies

Organization Description

Repair Biotechnologies develops the Cholesterol Degrading Platform (CDP), a first in class approach to therapy aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.

Team

Mourad Topors, Ph.D.

Repair Biotechnologies - Chief Scientific Officer

Reason

Repair Biotechnologies - CEO

Bill Cherman

Repair Biotechnologies

Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.

© 2025 Lifespan Research Institute – ALL RIGHTS RESERVED